BioCentury | Mar 17, 2021
Politics, Policy & Law

CMS drops plan to erode Medicare Part D protections, retains generic, biosimilar incentives

...forward with a policy allowing Part D beneficiaries to spread drug costs over a year. Steve Usdin Centers for Medicare & Medicaid Services Medicare biosimilars...
BioCentury | Jan 21, 2021
Politics, Policy & Law

Promising to put science first, Woodcock takes over as acting FDA commissioner

...administration loyalists. Steve Usdin U.S. Food and Drug Administration (FDA) Centers for Medicare & Medicaid Services Janet...
BioCentury | Nov 25, 2020
Emerging Company Profile

Building Resilience into U.S. biomanufacturing

...who formerly served as administrator of the Centers for Medicare & Medicaid Services...
BioCentury | Nov 21, 2020
Politics, Policy & Law

Fate of Trump’s 11th hour drug price rules uncertain

...Pharmaceuticals Inc. Pharmaceutical Research and Manufacturers of America (PhRMA) Centers for Medicare & Medicaid Services Biotechnology...
BioCentury | Oct 30, 2020
Politics, Policy & Law

CMS announces rule to cover costs of COVID-19 vaccines, therapeutics

...Medicare and Medicaid beneficiaries. The comment period for the CMS rule is open until Nov. 27. Danielle Golovin Centers for Medicare & Medicaid Services COVID-19 cov19count cov19pol chs2020 cov19count cov19pol...
BioCentury | Sep 1, 2020
Politics, Policy & Law

Proposed CMS pathway could be expanded to give therapies, diagnostics immediate, national coverage

...investigational; and appropriate for Medicare patients. Elizabeth S. Eaton Centers for Medicare & Medicaid Services breakthrough devices cms medicare coverage...
BioCentury | May 29, 2020
Politics, Policy & Law

Proposed CMS rule for CAR Ts marks progress in reimbursing new technologies

...the regenerative medicine sector. It serves as yet another validation point,” said Falb. Lauren Martz, Senior Editor Centers for Medicare & Medicaid Services Novartis...
BioCentury | Apr 15, 2020
Politics, Policy & Law

Medicare raises payments to increase high-throughput COVID-19 testing

...analysis of the coronavirus crisis can be found at https://www.biocentury.com/coronavirus . Steve Usdin, Washington Editor Hologic Inc. Abbott Laboratories Centers for Medicare & Medicaid Services NeuMoDx...
BioCentury | Apr 14, 2020
Regulation

New U.S. policies complicate regulatory calculus for COVID-19 antibody tests

...PT Karen Tkach Tuzman, Associate Editor U.S. Food and Drug Administration (FDA) U.S. Department of Health and Human Services Centers for Medicare & Medicaid Services covid-19 covid19 cov19count serological...
BioCentury | Mar 11, 2020
Politics, Policy & Law

Insulin companies commit to CMS program that caps Medicare out-of-pocket insulin costs

...covering the costs, this demonstration project will breakdown.” Steve Usdin, Washington Editor Eli Lilly and Co. Sanofi Novo Nordisk A/S Centers for Medicare & Medicaid Services insulin drug...
Items per page:
1 - 10 of 458
BioCentury | Mar 17, 2021
Politics, Policy & Law

CMS drops plan to erode Medicare Part D protections, retains generic, biosimilar incentives

...forward with a policy allowing Part D beneficiaries to spread drug costs over a year. Steve Usdin Centers for Medicare & Medicaid Services Medicare biosimilars...
BioCentury | Jan 21, 2021
Politics, Policy & Law

Promising to put science first, Woodcock takes over as acting FDA commissioner

...administration loyalists. Steve Usdin U.S. Food and Drug Administration (FDA) Centers for Medicare & Medicaid Services Janet...
BioCentury | Nov 25, 2020
Emerging Company Profile

Building Resilience into U.S. biomanufacturing

...who formerly served as administrator of the Centers for Medicare & Medicaid Services...
BioCentury | Nov 21, 2020
Politics, Policy & Law

Fate of Trump’s 11th hour drug price rules uncertain

...Pharmaceuticals Inc. Pharmaceutical Research and Manufacturers of America (PhRMA) Centers for Medicare & Medicaid Services Biotechnology...
BioCentury | Oct 30, 2020
Politics, Policy & Law

CMS announces rule to cover costs of COVID-19 vaccines, therapeutics

...Medicare and Medicaid beneficiaries. The comment period for the CMS rule is open until Nov. 27. Danielle Golovin Centers for Medicare & Medicaid Services COVID-19 cov19count cov19pol chs2020 cov19count cov19pol...
BioCentury | Sep 1, 2020
Politics, Policy & Law

Proposed CMS pathway could be expanded to give therapies, diagnostics immediate, national coverage

...investigational; and appropriate for Medicare patients. Elizabeth S. Eaton Centers for Medicare & Medicaid Services breakthrough devices cms medicare coverage...
BioCentury | May 29, 2020
Politics, Policy & Law

Proposed CMS rule for CAR Ts marks progress in reimbursing new technologies

...the regenerative medicine sector. It serves as yet another validation point,” said Falb. Lauren Martz, Senior Editor Centers for Medicare & Medicaid Services Novartis...
BioCentury | Apr 15, 2020
Politics, Policy & Law

Medicare raises payments to increase high-throughput COVID-19 testing

...analysis of the coronavirus crisis can be found at https://www.biocentury.com/coronavirus . Steve Usdin, Washington Editor Hologic Inc. Abbott Laboratories Centers for Medicare & Medicaid Services NeuMoDx...
BioCentury | Apr 14, 2020
Regulation

New U.S. policies complicate regulatory calculus for COVID-19 antibody tests

...PT Karen Tkach Tuzman, Associate Editor U.S. Food and Drug Administration (FDA) U.S. Department of Health and Human Services Centers for Medicare & Medicaid Services covid-19 covid19 cov19count serological...
BioCentury | Mar 11, 2020
Politics, Policy & Law

Insulin companies commit to CMS program that caps Medicare out-of-pocket insulin costs

...covering the costs, this demonstration project will breakdown.” Steve Usdin, Washington Editor Eli Lilly and Co. Sanofi Novo Nordisk A/S Centers for Medicare & Medicaid Services insulin drug...
Items per page:
1 - 10 of 458